Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDA.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDA.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.58.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.58.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.58.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.33NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.13.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.13.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.13.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GW.5.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GW.5.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.5.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.53.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.53.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.53.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDQ.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDQ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDQ.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HV.1.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HV.1.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KA.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KA.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HV.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HV.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.35NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.35NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.9.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.9.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.9.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.47.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.47.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.47.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used